Nitroprusside inhibits platelet function primarily by inhibiting Ca2+ mobilization.
Krishnamurthi
S
S
Thrombosis Research Unit, Rayne Institute, London, U.K.
Wheeler-Jones
C P
CP
Patel
Y
Y
Sadowska
K
K
Kakkar
V V
VV
Rao
G H
GH
D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000097:blood; D002118:Calcium / Q000097:blood*; D003094:Collagen / Q000494:pharmacology; D005292:Ferricyanides / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D009599:Nitroprusside / Q000494:pharmacology*; D010712:Phosphatidic Acids / Q000096:biosynthesis; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors; D011450:Prostaglandin Endoperoxides, Synthetic / Q000494:pharmacology; D012701:Serotonin / Q000097:blood; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D013917:Thrombin / Q000494:pharmacology
D001095:Arachidonic Acids; D005292:Ferricyanides; D010712:Phosphatidic Acids; D010975:Platelet Aggregation Inhibitors; D011450:Prostaglandin Endoperoxides, Synthetic; D009599:Nitroprusside; D016718:Arachidonic Acid; D012701:Serotonin; D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D003094:Collagen; D013917:Thrombin; D013755:Tetradecanoylphorbol Acetate; D002118:Calcium